[HTML][HTML] Radiopharmaceuticals for PET and SPECT imaging: a literature review over the last decade

G Crișan, NS Moldovean-Cioroianu… - International Journal of …, 2022 - mdpi.com
Positron emission tomography (PET) uses radioactive tracers and enables the functional
imaging of several metabolic processes, blood flow measurements, regional chemical …

[HTML][HTML] Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development

SP McCluskey, C Plisson, EA Rabiner… - European journal of …, 2020 - Springer
Purpose A limit on developing new treatments for a number of central nervous system (CNS)
disorders has been the inadequate understanding of the in vivo pathophysiology underlying …

Purinergic receptors of the central nervous system: biology, PET ligands, and their applications

H Zarrinmayeh, PR Territo - Molecular Imaging, 2020 - journals.sagepub.com
Purinergic receptors play important roles in central nervous system (CNS). These receptors
are involved in cellular neuroinflammatory responses that regulate functions of neurons …

History and Perspectives of A2A Adenosine Receptor Antagonists as Potential Therapeutic Agents

D Preti, PG Baraldi, AR Moorman… - Medicinal research …, 2015 - Wiley Online Library
Growing evidence emphasizes that the purine nucleoside adenosine plays an active role as
a local regulator in different pathologies. Adenosine is a ubiquitous nucleoside involved in …

[HTML][HTML] Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography

B Janssen, DJ Vugts, U Funke, GT Molenaar… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Neuroinflammation is thought to play a pivotal role in many diseases affecting the brain,
including Alzheimer's disease, multiple sclerosis and stroke. Neuroinflammation is …

[HTML][HTML] Allosteric Interactions between Adenosine A2A and Dopamine D2 Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics …

K Prasad, EFJ de Vries, PH Elsinga… - International Journal of …, 2021 - mdpi.com
Adenosine and dopamine interact antagonistically in living mammals. These interactions are
mediated via adenosine A2A and dopamine D2 receptors (R). Stimulation of A2AR inhibits …

New and emerging medical therapies in Parkinson's disease

M Lotia, J Jankovic - Expert opinion on pharmacotherapy, 2016 - Taylor & Francis
Introduction: Parkinson's disease (PD) is one of the most challenging neurodegenerative
disorders to treat as it manifests with a large variety of troublesome, and often disabling …

Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors

O Barret, J Hannestad, C Vala, D Alagille… - Journal of Nuclear …, 2015 - Soc Nuclear Med
PET with selective adenosine 2A receptor (A2A) radiotracers can be used to study a variety
of neurodegenerative and neuropsychiatric disorders in vivo and to support drug-discovery …

Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging

A van Waarde, RAJO Dierckx, X Zhou… - Medicinal Research …, 2018 - Wiley Online Library
Abstract Adenosine A2A receptors (A2ARs) are highly expressed in the human striatum, and
at lower densities in the cerebral cortex, the hippocampus, and cells of the immune system …

[HTML][HTML] Improved in vivo PET imaging of the adenosine A2A receptor in the brain using [18F]FLUDA, a deuterated radiotracer with high metabolic stability

TH Lai, M Toussaint, R Teodoro… - European journal of …, 2021 - Springer
Abstract Purpose The adenosine A 2A receptor has emerged as a therapeutic target for
multiple diseases, and thus the non-invasive imaging of the expression or occupancy of the …